henhaobio
Sign in

Proceedings of the National Academy of SciencesPharmacology & ToxicologyPeer-reviewed journal article

12/15-Lipoxygenase orchestrates murine wound healing via PPARg-activating oxylipins acting holistically to dampen inflammation.

Christopher P. ThomasiD, Victoria J. TyrrelliD, James J. BurstoniD, Sam R. C. Johnson, Maceler AldrovandiiD, Jorge Álvarez-JarretaiD, Rossa InglisiD, Adam LeonardiD, Lydia Fice, Jeremie Costales, Antonio Vidal‐PuigiD, Majd B. ProttyiD, Carol GuyiD, Robert AndrewsiD, Barbara SzomolayiD, Benjamin C. CossinsiD, Ana Cardus FiguerasiD, Stefania CarobbioiD, Simon A. JonesiD, Valerie B. O’DonnelliD

PDFDOIPreprint

In-depth summary

Claude Opus 5.5 · xhigh effort · 8 Nov 2026 · from the full text of version 1 (27 Mar 2025) · CC BY 4.0

Alox15-deficient mice heal skin punch wounds with excess collagen, low matrix metalloproteinase activity and unresolved inflammatory gene expression; topical physiological 12/15-lipoxygenase oxylipin mixtures reduced collagen and raised collagenase activity.

The physiological role of macrophage 12/15-lipoxygenase (12/15-LOX, Alox15) in resolving wound healing has been unclear, because earlier work tested its lipid products one at a time at pharmacological doses rather than as the mixtures made in vivo. This work tests the enzyme genetically in mouse skin wounds and reconstitutes knockout wounds with lipid mixtures dosed from measured wound levels, pointing to a PPARγ/adiponectin axis.

Key results

  1. ShownAlox15 deletion gives a pro-fibrotic, pro-inflammatory wound: more collagen and myofibroblast actin, more SSEA3+ stem cells, raised pSTAT3, pSMAD3 and IFNγ, lower CD206 and lower matrix metalloproteinase (MMP) collagenase activity. Keratinocyte re-epithelialization is unchanged.

    Masson trichrome collagen higher in Alox15-/- wounds on days 7 and 14 (n = 10-14/group); by immunohistochemistry pSTAT3 (n = 5-6/group), pSMAD3 (n = 10-11/group) and IFNγ (n = 9/group) up and CD206 (n = 5/group) down; day 7 gelatin zymography showed significantly lower active MMP2, pro-MMP2 and MMP9 activity (n = 6/group). IL6 protein and day-4 keratinocyte migration did not differ significantly. · Alox15 deletion alters the phenotype of the…; Elevated TGFβ/IFNγ/IL6 activity is seen in the…; Alox15-/- wounds show reduced matrix…; Figure legends

  2. ShownWounding induced 12/15-LOX by 24 hrs, mainly in F4/80+ macrophages and hair-follicle stem cells. Its free monohydroxy products peaked at day 1 and were lost or halved in Alox15-/- wounds. Canonical specialized pro-resolving mediators (SPMs) were essentially absent.

    Of ~100 oxidized fatty acids targeted by LC/MS/MS, 68 were detected. 15-HEPE, 14-HDOHE, 17-HDOHE and 13-HOTrE were absent in Alox15-/-, and 12-HETE/12-HEPE and 15-HETE/15-HETrE fell by 50%; 5-LOX and COX products were unaffected. Esterified 12-HETE-PE was reduced by >50%. Only trace RvD5 was found (max 1.5 pg/wound, around 4 fmol/wound). · Tissue 12/15-LOX is acutely induced by wounding…; The temporal profile of oxylipins is altered by…; Enzymatically-oxidized phospholipids (eoxPL) are…; Discussion

  3. ShownA topical high-oxylipin mixture of abundant 12/15-LOX-dependent lipids, dosed to match peak wound levels, raised MMP activity and reduced collagen deposition relative to vehicle in Alox15-/- wounds. An oxidized phospholipid (PE 18:0a/12-HETE) had no effect.

    Lipids were applied on days 0, 2, 4 and 6; wounds analyzed at day 7. MMP9, active MMP2 and pro-MMP2 activities rose to levels between wild type and Alox15-/- (zymography, n = 4 pools of 4-5 wounds). The non-significant collagen increase seen with vehicle was completely suppressed by the high-oxylipin mixture (Masson trichrome, n = 5-6 wounds/group). Total oxylipin dose was 6.5 ng per wound per day. · MMP activities and collagen deposition are…; Discussion; Animal model; Figure legends

  4. ShownUnwounded Alox15-/- skin has lower Pparg and Adipoq expression. The inflammatory response at day 4 starts normally, but a co-regulated pro-inflammatory gene module fails to return to baseline by day 7.

    DESeq2 (adjusted p < 0.05): 143 genes differed at day 0, around 42 at day 4 and 79 at day 7 (60 higher in Alox15-/-). A 45-gene module (Pearson |r| > 0.8; e.g. Il1b, Il6, Nlrp3, Ptgs2, Cxcl2, Trem1) stayed around 50% of day 4 levels in Alox15-/- at day 7 but returned to basal in wild type. Ingenuity Pathway Analysis (IPA) predicted higher IL1, IFNβ and inflammasome activity. · Transcriptional analysis reveals reduced…; Late wound healing in Alox15-/- wounds shows a…; Animal model; Statistical Analysis

  5. SuggestedThe high-oxylipin mixture activated PPARγ in a cell reporter assay, but only at concentrations around 100-fold above those found in vivo. Doses matched to a single wound did not reliably activate it.

    HEK293 cells expressing mouse PPARγ and a 3x PPRE-luciferase reporter: 0.4-1.2 μM total oxylipins (content of single day-1 wounds) gave no reliable activation; 40-120 μM total (12-HETE 12-36 μM) activated PPARγ, significantly at 80 μM (3 independent experiments). The PPARγ coactivator Helz2 rose significantly at days 4 and 7 in both strains; it is proposed as a sensitizer but not tested. · Late wound healing in Alox15-/- wounds shows a…; Wounding induces significant increases in gene…; Discussion; Cell transfection and reporter assays

Methods, data and reproducibility

Alox15-/- and wild-type C57BL/6J mice were given 4 mm dorsal punch wounds, profiled to day 14 by immunohistochemistry, collagen staining, gelatin zymography, LC/MS/MS of free oxylipins and HETE-phospholipids, and total RNA-seq (days 0, 4, 7). Knockout wounds were then topically treated with lipid mixtures matched to measured wound levels, and the mixture was tested in a PPARγ luciferase reporter.

  • Wild-type and Alox15-/- dorsal skin punch wounds analyzed by histology, immunohistochemistry and gelatin zymography up to day 14 · mouse · n = varies by assay (e.g. 10-14/group for collagen; 6/group for zymography)
  • Wound LC/MS/MS lipidomics time course: free oxylipins and HETE-containing phosphatidylethanolamines, plus chiral analysis of 7,17-diHDOHE · mouse · n = 5-6 samples/time point for oxylipins, 5 for HETE-PEs; 4 wounds pooled per sample
  • Total RNA-seq (rRNA-depleted, HiSeq4000 2x75bp) of unwounded skin (day 0) and wounds at days 4 and 7, male mice only; one wild-type baseline sample removed after QC · mouse · n = 4 samples per condition, each pooling 8 wounds from 2 mice
  • Alox15-/- wounds treated topically with high-oxylipin mixture, PE 18:0a/12-HETE or vehicle, harvested at day 7 · mouse · n = 4 pooled samples (MMP); 5-6 wounds/group (collagen)
  • HEK293 cells transfected with mouse PPARγ and 3x PPRE Firefly luciferase reporter, Renilla internal control · human (HEK293 cell line), expressing mouse PPARγ · n = 4 replicates per condition, 3 independent experiments
Methods & tools
Sciex QTRAP 6500 LC/MS/MS with MultiQuant 3.0.2, Chiralpak IA-U chiral column, Illumina TruSeq Stranded Total RNA kit, HiSeq4000, Trimmomatic / FastQC, STAR, FeatureCounts, DESeq2, Ingenuity Pathway Analysis (IPA), Cytoscape, STRING 11.5, ImageJ, Dual-Luciferase Reporter Assay System (Promega)
Reagents & environment
MultiQuant 3.0.2; MATLAB R2022a; STRING 11.5; reads mapped to GRCm38 with the Ensembl GRCm38.84 GTF. Versions of Trimmomatic, STAR, FeatureCounts and DESeq2 are not stated.
Reproducibility gaps
No code repository or data accession for RNA-seq or lipidomics is given. The R heatmap script is mentioned without a link, and assay parameters and several analyses sit in supplementary tables and methods that are not part of this text.
Limitations (6)
  • PPARγ activation in vitro needed oxylipin concentrations about 100-fold higher than those in wounds. True local wound concentrations and cellular uptake cannot be determined, and whether Helz2 sensitizes PPARγ to oxylipins is untested. · stated by the authors
  • Elf4, Tcf3 and Cebpb, nominated by temporal RNA-seq and IPA upstream-regulator analysis, may play roles, but their functions in healing are not established. · stated by the authors
  • Several HETE-PE identifications are putative, resting on precursor/product ions and retention times, because synthetic standards were limited (none for 16:0p, 18:0p and 18:1 forms). · stated by the authors
  • Trace RvD5 may arise from non-enzymatic secondary oxidation of 17S-HDOHE. 5-LOX inhibition and MS/MS of the 7R,17S epimer would be needed to settle its origin. · stated by the authors
  • The PPARγ mechanism is inferred from transcript levels, a HEK293 reporter and resemblance to published PPARγ-deficient phenotypes. No PPARγ antagonist or genetic PPARγ manipulation is reported in the wound rescue experiments. · noted in this summary
  • The rescue and transcriptomic arms are small (4 pooled MMP samples, 5-6 wounds for collagen, 3-4 RNA-seq pools from males only, one wild-type baseline sample dropped after QC), and no data accession or code is provided. · noted in this summary

Read this if you study lipid mediators, PPARγ signaling or fibrosis in wound repair and want an example of rescuing a knockout with lipid mixtures dosed from measured tissue lipidomics.

Citations
12
FWCI
4.08
Field percentile
top 6%

Abstract

12/15-lipoxygenase (12/15-LOX, Alox15) generates bioactive oxygenated lipids during inflammation, however its homeostatic role(s) in normal healing are unclear. Here, the role of 12/15-LOX in resolving skin wounds was elucidated, focusing on how its lipids act together in physiologically relevant amounts. In mice, wounding caused acute appearance of 12/15-LOX-expressing macrophages and stem cells, coupled to early generation of [~]12 monohydroxy-oxylipins and enzymatically oxygenated phospholipids (eoxPL). Alox15 deletion increased -smooth muscle actin, collagen deposition, stem cell/fibroblast proliferation, IL6/pSTAT3, pSMAD3, and IFN-{gamma} levels. Conversely, CD206 expression, F480+ cells, MMP9 and MMP2 activities were reduced. Alox15-/- skin was deficient in PPAR{gamma}/adiponectin activity. Furthermore, while pro-inflammatory genes were upregulated as normal during wounding, many including Il6, Il1b, ccl4, Cd14, Cd274, Clec4d, Clec4e, Csf3, and Cxcl2 failed to revert to baseline during healing, indicating disruption of an anti-inflammatory brake. Reconstituting Alox15-/- wounds with a physiological mixture of Alox15-derived primary oxylipins generated by healing wounds restored MMP and dampened collagen deposition. The oxylipin mixture activated PPAR{gamma} in vitro, while in vivo, the PPAR{gamma} co-activator, Helz2, was significantly upregulated. Additional inflammatory and proliferative gene networks impacted by Alox15-/-included Elf4, Cebpb and Tcf3, with many of their associated genes significantly dysregulated. In summary, the impact of 12/15-LOX is ascribed to the deficiency of abundantly generated monohydroxy oxylipins acting together via PPAR{gamma}/adiponectin. The identification of multiple gene alterations reveals several new targets for treatment of non-healing wounds. Our studies demonstrate that abundant 12/15-LOX oxylipins act together, dampening inflammation in vivo, revealing a need to consider lipid signaling holistically. Significance statementDefective wound healing is a significant global clinical problem. Macrophage 12/15-lipoxygenase (12/15-LOX, Alox15) generates abundant lipid mediators termed oxylipins during inflammation. However, its physiological role during resolving wound healing is unclear, with studies so far assessing the bioactivity of individual lipids pharmacologically, rather than holistically in physiological amounts. Here, we report that Alox15 deficiency in mice caused a fibrotic response with failure to dampen inflammation, due to a dysregulated PPAR{gamma}/adiponectin axis. Treatment of Alox15-/- wounds with physiological mixtures of PPAR{gamma}-activating 12/15-LOX primary monohydroxy products restored the phenotype. Several transcriptional networks (Elf4, Cebpb and Tcf3) controlled by Alox15 were uncovered, identifying new targets for promoting physiological wound healing.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.